vs
KOHLS Corp（KSS）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是KOHLS Corp的1.5倍（$5.5B vs $3.6B），TENET HEALTHCARE CORP净利率更高（11.7% vs 0.2%，领先11.4%），TENET HEALTHCARE CORP同比增速更快（9.0% vs -3.6%），TENET HEALTHCARE CORP自由现金流更多（$367.0M vs $16.0M），过去两年TENET HEALTHCARE CORP的营收复合增速更高（1.5% vs -22.5%）
科尔士（Kohl's）是美国知名连锁百货零售商，目前在全美除夏威夷外的各州共开设1174家门店。品牌由波兰移民麦克斯韦·科尔创立，1927年他在威斯康星州密尔沃基开设了一家街角杂货店，在当地发展为成功的连锁品牌后，1962年公司开设首家百货门店，正式进军百货零售领域。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
KSS vs THC — 直观对比
营收规模更大
THC
是对方的1.5倍
$3.6B
营收增速更快
THC
高出12.6%
-3.6%
净利率更高
THC
高出11.4%
0.2%
自由现金流更多
THC
多$351.0M
$16.0M
两年增速更快
THC
近两年复合增速
-22.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.6B | $5.5B |
| 净利润 | $8.0M | $644.0M |
| 毛利率 | 42.4% | — |
| 营业利润率 | 2.0% | 15.4% |
| 净利率 | 0.2% | 11.7% |
| 营收同比 | -3.6% | 9.0% |
| 净利润同比 | -63.6% | 12.6% |
| 每股收益（稀释后） | $0.07 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KSSTHC
| Q4 25 | $3.6B | $5.5B | ||
| Q3 25 | $3.5B | $5.3B | ||
| Q2 25 | $3.2B | $5.3B | ||
| Q1 25 | $5.4B | $5.2B | ||
| Q4 24 | $3.7B | $5.1B | ||
| Q3 24 | $3.7B | $5.1B | ||
| Q2 24 | $3.4B | $5.1B | ||
| Q1 24 | $6.0B | $5.4B |
净利润KSSTHC
| Q4 25 | $8.0M | $644.0M | ||
| Q3 25 | $153.0M | $579.0M | ||
| Q2 25 | $-15.0M | $522.0M | ||
| Q1 25 | $48.0M | $622.0M | ||
| Q4 24 | $22.0M | $572.0M | ||
| Q3 24 | $66.0M | $681.0M | ||
| Q2 24 | $-27.0M | $477.0M | ||
| Q1 24 | $186.0M | $2.3B |
毛利率KSSTHC
| Q4 25 | 42.4% | — | ||
| Q3 25 | 43.3% | — | ||
| Q2 25 | 43.3% | — | ||
| Q1 25 | 35.6% | — | ||
| Q4 24 | 42.4% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 43.1% | — | ||
| Q1 24 | 35.2% | — |
营业利润率KSSTHC
| Q4 25 | 2.0% | 15.4% | ||
| Q3 25 | 7.9% | 16.8% | ||
| Q2 25 | 1.9% | 15.6% | ||
| Q1 25 | 2.3% | 18.1% | ||
| Q4 24 | 2.6% | 16.2% | ||
| Q3 24 | 4.4% | 21.3% | ||
| Q2 24 | 1.3% | 14.9% | ||
| Q1 24 | 5.0% | 61.2% |
净利率KSSTHC
| Q4 25 | 0.2% | 11.7% | ||
| Q3 25 | 4.3% | 10.9% | ||
| Q2 25 | -0.5% | 9.9% | ||
| Q1 25 | 0.9% | 11.9% | ||
| Q4 24 | 0.6% | 11.3% | ||
| Q3 24 | 1.8% | 13.3% | ||
| Q2 24 | -0.8% | 9.3% | ||
| Q1 24 | 3.1% | 43.5% |
每股收益（稀释后）KSSTHC
| Q4 25 | $0.07 | $4.22 | ||
| Q3 25 | $1.35 | $3.86 | ||
| Q2 25 | $-0.13 | $3.14 | ||
| Q1 25 | $0.43 | $4.27 | ||
| Q4 24 | $0.20 | $3.79 | ||
| Q3 24 | $0.59 | $4.89 | ||
| Q2 24 | $-0.24 | $2.64 | ||
| Q1 24 | $1.67 | $21.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $144.0M | $2.9B |
| 总债务越低越好 | — | $13.1B |
| 股东权益账面价值 | $3.9B | $4.2B |
| 总资产 | $14.1B | $29.7B |
| 负债/权益比越低杠杆越低 | — | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资KSSTHC
| Q4 25 | $144.0M | $2.9B | ||
| Q3 25 | $174.0M | $3.0B | ||
| Q2 25 | $153.0M | $2.6B | ||
| Q1 25 | $134.0M | $3.0B | ||
| Q4 24 | $174.0M | $3.0B | ||
| Q3 24 | $231.0M | $4.1B | ||
| Q2 24 | $228.0M | $2.9B | ||
| Q1 24 | $183.0M | $2.5B |
总债务KSSTHC
| Q4 25 | — | $13.1B | ||
| Q3 25 | — | $13.1B | ||
| Q2 25 | — | $13.1B | ||
| Q1 25 | — | $13.1B | ||
| Q4 24 | — | $13.1B | ||
| Q3 24 | — | $12.8B | ||
| Q2 24 | — | $12.8B | ||
| Q1 24 | — | $12.8B |
股东权益KSSTHC
| Q4 25 | $3.9B | $4.2B | ||
| Q3 25 | $3.9B | $4.0B | ||
| Q2 25 | $3.8B | $3.7B | ||
| Q1 25 | $3.8B | $4.2B | ||
| Q4 24 | $3.8B | $4.2B | ||
| Q3 24 | $3.8B | $3.8B | ||
| Q2 24 | $3.8B | $3.5B | ||
| Q1 24 | $3.9B | $3.5B |
总资产KSSTHC
| Q4 25 | $14.1B | $29.7B | ||
| Q3 25 | $13.4B | $29.4B | ||
| Q2 25 | $13.6B | $28.7B | ||
| Q1 25 | $13.6B | $29.2B | ||
| Q4 24 | $15.1B | $28.9B | ||
| Q3 24 | $14.2B | $29.4B | ||
| Q2 24 | $14.3B | $29.3B | ||
| Q1 24 | $14.0B | $28.9B |
负债/权益比KSSTHC
| Q4 25 | — | 3.10× | ||
| Q3 25 | — | 3.26× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | 3.13× | ||
| Q4 24 | — | 3.14× | ||
| Q3 24 | — | 3.33× | ||
| Q2 24 | — | 3.67× | ||
| Q1 24 | — | 3.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $124.0M | $731.0M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $367.0M |
| 自由现金流率自由现金流/营收 | 0.4% | 6.6% |
| 资本支出强度资本支出/营收 | 3.0% | 6.6% |
| 现金转化率经营现金流/净利润 | 15.50× | 1.14× |
| 过去12个月自由现金流最近4个季度 | $819.0M | $2.5B |
8季度趋势，按日历期对齐
经营现金流KSSTHC
| Q4 25 | $124.0M | $731.0M | ||
| Q3 25 | $598.0M | $1.1B | ||
| Q2 25 | $-92.0M | $936.0M | ||
| Q1 25 | $596.0M | $815.0M | ||
| Q4 24 | $-195.0M | $-331.0M | ||
| Q3 24 | $254.0M | $1.0B | ||
| Q2 24 | $-7.0M | $747.0M | ||
| Q1 24 | $789.0M | $586.0M |
自由现金流KSSTHC
| Q4 25 | $16.0M | $367.0M | ||
| Q3 25 | $508.0M | $778.0M | ||
| Q2 25 | $-202.0M | $743.0M | ||
| Q1 25 | $497.0M | $642.0M | ||
| Q4 24 | $-323.0M | $-661.0M | ||
| Q3 24 | $141.0M | $829.0M | ||
| Q2 24 | $-133.0M | $602.0M | ||
| Q1 24 | $707.0M | $346.0M |
自由现金流率KSSTHC
| Q4 25 | 0.4% | 6.6% | ||
| Q3 25 | 14.3% | 14.7% | ||
| Q2 25 | -6.2% | 14.1% | ||
| Q1 25 | 9.2% | 12.3% | ||
| Q4 24 | -8.7% | -13.0% | ||
| Q3 24 | 3.8% | 16.2% | ||
| Q2 24 | -3.9% | 11.8% | ||
| Q1 24 | 11.9% | 6.4% |
资本支出强度KSSTHC
| Q4 25 | 3.0% | 6.6% | ||
| Q3 25 | 2.5% | 5.3% | ||
| Q2 25 | 3.4% | 3.7% | ||
| Q1 25 | 1.8% | 3.3% | ||
| Q4 24 | 3.5% | 6.5% | ||
| Q3 24 | 3.0% | 4.2% | ||
| Q2 24 | 3.7% | 2.8% | ||
| Q1 24 | 1.4% | 4.5% |
现金转化率KSSTHC
| Q4 25 | 15.50× | 1.14× | ||
| Q3 25 | 3.91× | 1.83× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | 12.42× | 1.31× | ||
| Q4 24 | -8.86× | -0.58× | ||
| Q3 24 | 3.85× | 1.53× | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | 4.24× | 0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KSS
| Products | $3.4B | 95% |
| Other | $168.0M | 5% |
| Gift Card | $17.0M | 0% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
